Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective.

ABSTRACT:

Background

The coronavirus disease 2019 [COVID-19] pandemic is affecting lives worldwide. The influence of inflammatory bowel disease [IBD] medication and IBD itself on COVID-19 is controversial. Additionally, IBD-focused guidance is scarce.

Objective

Our aims were to determine COVID-19 prevalence/exposure, perception and information sources, medication compliance, patient behaviour and physician contact among patients with IBD compared with non-IBD controls.

Methods

A cross-sectional anonymous survey of patients with IBD [N = 415] at one university IBD clinic and one gastroenterology practice, matched 4:1 with control participants [N = 116], was performed.

Results

Patients with IBD had a high fear of infection. This was more pronounced in patients taking immun

SUBMITTER: Grunert PC 

PROVIDER: S-EPMC7337669 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature